Three times more vaccinated people died during the omicron peak than during delta’s heyday in California's Bay Area

A Bay Area News Group analysis of state COVID-19 deaths found that from Aug. 25 to Sept. 21, the deadliest four weeks of the delta surge when the variant accounted for 98% or more of genetically sequenced cases, 2,917 unvaccinated and 533 vaccinated people died.

From Jan. 14 to Feb. 10, the deadliest period of the omicron surge when the variant was 98% or more of sequenced cases, 2,999 unvaccinated and 1,767 vaccinated people died, including 436 who’d received booster shots to shore up waning vaccine protection. 


State figures have consistently shown the coronavirus is deadlier with age. Of the nearly 85,000 Californians who’ve died of COVID-19, 71% were age 65 or older and 92% at were least 50.

In Santa Cruz, 10 patients lost their lives to COVID-19 in the end of January and beginning of February 2022. All but one were vaccinated, and five had received booster shots. Off the vaccinated patients who died, one was in his early 100s, three were in their 90s, two were in their 80s, three were in their 70s and most (but not all) had underlying health problems. The unvaccinated man who died was in his 50s.


By John Woolfolk, Harriet Blair Rowan and Emily DeRuy | Bay Area News Group

PUBLISHED: March 6, 2022

REFERENCES

The Mercury News – Mar 06 2022

Also blogged at:

COVID-19 deaths in California among vaccinated rose sharply with omicron – TWO PLUS TWO EQUALS FOUR (wordpress.com)

California Omicron Deaths Surprisingly High Among Vaccinated Patients | Kaiser Health News (khn.org)


Comments

Post a Comment

Popular posts from this blog

A New Onset of Ulcerative Colitis post-2nd-breakthrough-COVID-19

Image
A 21-year-old non-smoking Caucasian male with a history of acute pancreatitis but no other medical issues or family history had two doses of the BNT162b2 mRNA COVID-19 vaccine.  Four months after the second dose he had his first episode of COVID-19. Although not hypoxic, he felt pretty unwell for a week, with a severe cough, fever, generalized body ache, headache, and loss of taste. He received the third dose of the vaccine two months after recovering from COVID. Nine months after the third dose, he had the second episode of COVID-19, during which he was mildly unwell for three days, recovered, and did not require any anti-viral medication or antibiotics. One week post the second episode of COVID-19, he developed diarrhea and abdominal pain. It then progressed to bloody diarrhea. Ulcerative colitis was diagnosed based on his clinical symptoms, biopsy changes, and the exclusion of other causes.  There are ten published case reports about the newly diagnosed ulcerative colitis associate
Read more

COVID in May

Image
Concerns about a potential resurgence of COVID-19 are mounting as summer 2024 approaches.  This is driven by several indicators, including social media posts, healthcare data, and wastewater surveillance across different regions. Our study findings corroborate this trend.  While many forecasters anticipate a surge, others expect a gradual increase through the end of May, and then a decline again around early June. Reports from social media suggest emerging clusters of COVID-19 in Texas, several Canadian provinces, the UK, and on cruises in northern regions such as a Norwegian cruise to Alaska.  Data from Alberta's Respiratory virus dashboard   (total weekly laboratory-confirmed COVID-19 cases) and wastewater surveillance in Calgary indicate an uptick in COVID-19 cases starting April 2024. The most recent statistics from Alberta Health reveal a significant increase in hospitalizations due to COVID-19, with 114 individuals currently hospitalized—an increase of more than 20% over two
Read more

Chronic SARS-CoV-2 Shedding

Image
Chronic viral shedding, a condition where the virus continues to be released from an individual's body long after the initial infection, has been observed in many infectious diseases, including COVID-19.  In such cases, individuals may remain asymptomatic or experience only mild symptoms while the virus persists. It remains detectable in repeated tests over an extended period and can still infect others even in nasal swab is negative (which happens quite often ). This was evident in our study.    Recent research by Conway et al. (2024) highlights the possibility of chronic SARS-CoV-2 infection, extending over several months and potentially years. Other studies have documented prolonged asymptomatic infections and extended viral shedding in moderate to severe beyond hospital discharge. Analysis of sequencing data on UK samples taken between 2 November 2020 and 15 August 2022 lead to estimates that 0.1–0.5% of infections may become persistent with typically rebounding high viral load
Read more